((自动化翻译由路透提供，请见免责声明 ))
11月15日 - * (link) * 在生物技术公司Halozyme 向德国药物开发公司Evotec 提出20亿欧元(21.1亿美元的) 收购要约后，该公司在Lang&Schwarz的盘前指数中上涨了约20%。
** 该公司表示，它打算以每股 11 欧元的价格收购 Evotec 的所有股份，与周四的收盘价相比，溢价 27.5%。
** 周一 Evotec 因私人投资公司 Triton 购买 (link) 超过 9% 的股份并考虑潜在收购的消息而上涨
** 一位当地交易商说，关于Halozyme的消息可能引发一场收购战
** Evotec 公司在一份声明中表示，将对 Halozyme 公司表达的意向进行分析，并决定下一步行动。
(1 美元 = 0.9493 欧元)
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.